Conversely, the HLA-DQB1*02 allele is related to a lower treatment requirement, which could represent a protective allele in hiMBL/CLL, perhaps indicating that patients carrying this specificity are more able to control the CLL tumor clone. The gene discussed is HLA-DQB1; the disease is B-cell chronic lymphocytic leukemia.